Be Bio News and Resources

Be Bio, has successfully closed a $92 million Series C financing round. The funding was backed by new investor Nextech, along with existing investors such as ARCH Venture Partners, Atlas Venture, RA Capital Management, Alta Partners, Longwood Fund, Bristol Myers